Stock Earnings
Ultragenyx Pharmaceutical Inc. [RARE] Records 200-Day SMA of $47.05
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.